-
Signature
-
/s/ Jason Minio, Attorney-in-Fact
-
Issuer symbol
-
CXM
-
Transactions as of
-
15 Jun 2023
-
Net transactions value
-
-$52,781
-
Form type
-
4
-
Filing time
-
20 Jun 2023, 17:39:03 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CXM |
Class A Common Stock |
Conversion of derivative security |
|
+861 |
+0.31% |
|
283,039 |
15 Jun 2023 |
Direct |
F1 |
| transaction |
CXM |
Class A Common Stock |
Sale |
$12,915 |
-861 |
-0.3% |
$15.00 |
282,178 |
15 Jun 2023 |
Direct |
F2 |
| transaction |
CXM |
Class A Common Stock |
Sale |
$43,301 |
-2,974 |
-1.1% |
$14.56 |
279,204 |
16 Jun 2023 |
Direct |
F3, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CXM |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-861 |
-0.79% |
$0.000000 |
107,472 |
15 Jun 2023 |
Class B Common Stock |
861 |
$3.99 |
Direct |
F2, F5 |
| transaction |
CXM |
Class B Common Stock |
Options Exercise |
$3,435 |
+861 |
+0.66% |
$3.99 |
131,861 |
15 Jun 2023 |
Class A Common Stock |
861 |
|
Direct |
F1, F2 |
| transaction |
CXM |
Class B Common Stock |
Conversion of derivative security |
$0 |
-861 |
-0.65% |
$0.000000 |
131,000 |
15 Jun 2023 |
Class A Common Stock |
861 |
|
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: